Publication | Closed Access

Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-κB: implications for angioprevention and antiangiogenic therapy

AngiogenesisChemoprevention StrategyMedicineEndothelial DysfunctionCell Cycle ArrestVascular BiologyPharmacotherapyHuman Endothelial CellsNeovascularizationPharmacologyRadiation OncologyCell SignalingAntiangiogenic TherapyMolecular Signaling